What is the dosage of Zolgensma?

Zolgensma is available in 24 dosages, including 20,000,000,000,000 vector-genomes/ml Injection 5.5 ml, 20,000,000,000,000 vector-genomes/ml Injection 8.3 ml, mixed Pack, mixed Pack, mixed Pack, mixed Pack, mixed Pack, mixed Pack, mixed Pack, mixed Pack, mixed Pack, mixed Pack, mixed Pack, mixed Pack, mixed Pack, mixed Pack, mixed Pack, mixed Pack, mixed Pack, mixed Pack, mixed Pack, mixed Pack, mixed Pack and mixed Pack

What does Zolgensma treat?

Zolgensma treats Spinal Muscular Atrophy

What is Zolgensma made of?

Zolgensma contains onasemnogene abeparvovec which is a undefined

How is Zolgensma administered?

Zolgensma is administered as a Injectable or Pack

What is Zolgensma mechanism of action?

Zolgensma mechanism of action is

Dosage & Administration Drug label Samples Prior authorization Financial assistance

Patient education

Zolgensma

(onasemnogene abeparvovec)

5.5 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]

BLACK BOX WARNING

Dosage & administration

ZOLGENSMA is for single-dose intravenous infusion only .

* The recommended dosage of ZOLGENSMA is 1.1 × 1014 vector genomes (vg) per kg of body weight.
* Administer ZOLGENSMA as an intravenous infusion over 60 minutes.
* Postpone ZOLGENSMA in patients with concurrent infections until the infection has resolved. Clinical signs or symptoms of infection should not be evident at the time of ZOLGENSMA administration.
* Starting one day prior to ZOLGENSMA infusion, administer systemic corticosteroids equivalent to oral prednisolone at 1 mg/kg of body weight per day for a total of 30 days.
* At the end of the 30-day period of systemic corticosteroid treatment, check liver function by clinical examination and by laboratory testing. For patients with unremarkable findings, taper the corticosteroid dose gradually over the next 28 days. If liver function abnormalities persist, continue systemic corticosteroids (equivalent to oral prednisolone at 1 mg/kg/day) until findings become unremarkable, and then taper the corticosteroid dose gradually over the next 28 days or longer if needed. Do not stop systemic corticosteroids abruptly.
* If liver function abnormalities continue to persist ≥ 2 × ULN after the 30-day period of systemic corticosteroids, consult a pediatric gastroenterologist or hepatologist.

drug label

Zolgensma prescribing information

Have more Zolgensma questions?

Submit MSL Request

Learn More

Need to report a Zolgensma issue?

ONLINE FORMReport adverse event

Learn More

samples

Request Zolgensma samples

NOT PROVIDED BY BRANDView Online Sample Form

Learn More

prior authorization

Zolgensma Prior authorization resources

NOT PROVIDED BY BRANDComplete Letter of Medical Necessity

NOT PROVIDED BY BRANDCoverage Authorization Request

NOT PROVIDED BY BRANDCoverage Authorization Appeals

Learn More

Benefits investigation

Zolgensma Prescription and Patient Consent Forms

Learn More

Reimbursement help (FRM)

NOT PROVIDED BY BRANDReimbursement help (FRM) resources

Learn More

financial assistance

Zolgensma Financial assistance options

Co-pay savings program

commercial only

NOT PROVIDED BY BRANDEnroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Bridge program

commercial only

Learn More

Overview

Provide patient immediate access to therapy during an insurance delay (typically new starts; some may cover change in insurance)
Limited time/ fill (typically 7-30 days; some may offer additional fill for continued delay up to certain limit)

Patient benefit

100% free (outside of insurance)

Patient eligibility

HCP must enroll patient
May be limited to commercially insured patients (i.e., no government beneficiaries); some programs may allow government beneficiaries

How to sign up

Typically HCP assisted enrollment (via form)

Foundation programs

under insured

no insurance

goverment insurance

65+

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement

patient education

Zolgensma Patient education

Getting started on Zolgensma

NOT PROVIDED BY BRANDInstructions For Use - Spinal Muscular Atrophy (SMA)

Patient toolkit

About Zolgensma

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Patient Resources

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Patient Stories

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Learn More

Can't find what you're looking for?

Our trained staff can help you:

Please note:

Access to a Field Reimbursement Manager (FRM) or Medical Science Liaison (MSL) varies by brand and may require talking with your rep first.
Samples are provided at the discretion of the brand.
We are unable to collect Protected Health Information (PHI), fill out forms, or submit them on your behalf.

Zolgensma

Dosage & administration

drug label

Zolgensma prescribing information

Have more Zolgensma questions?

Need to report a Zolgensma issue?

samples

Request Zolgensma samples

Is my patient elegible for Zolgensma samples?

How do I find out who my Zolgensma rep is?

prior authorization

Zolgensma Prior authorization resources

Benefits investigation

Reimbursement help (FRM)

financial assistance

Zolgensma Financial assistance options

Co-pay savings program

Overview

Patient benefit

Patient eligibility

How to sign up

Bridge program

Overview

Patient benefit

Patient eligibility

How to sign up

Foundation programs

Overview

Patient benefit

Patient eligibility

How to sign up

patient education

Zolgensma Patient education

Getting started on Zolgensma

Patient toolkit

Can't find what you're looking for?